findmyKOL
Clinical trialNCT02772003Active, not recruitingPhase 1Interventional

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

SponsorNational Cancer Institute (NCI)Enrollment33Chronic HepatitisHepatitis C InfectionHepatocellular Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase I trial studies the side effects and best dose of deoxyribonucleic acid (DNA) vaccine therapy in treating patients with hepatitis C virus (HCV) infection that persists or progresses over a long period of time. Vaccines made from DNA may help the body build an effective immune response to kill cancer cells that express HCV infection.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • University of Puerto Rico

    San Juan, Puerto Rico

United States
  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

  • Case Western Reserve University

    Cleveland, Ohio, United States

  • Temple University Hospital

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Electroporation-Mediated Plasmid DNA Vaccine TherapyHCV DNA Vaccine INO-8000Rocakinogene sifuplasmid
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Jun 2016
Primary completion
4 Mar 2020
Completion
9 Mar 2027
Last update posted
28 Jul 2026
Registered enrollment
33
Registry id
NCT02772003

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.